Follicle Stimulating Hormone

• 

  Subject Areas on Research

  • A comparative study of synthetic gonadotrophin releasing hormone decapeptide with a synthetic analogue (desGly-NH2(10)-pro-ethylamide) luteinizing hormone/follicle-stimulating hormone releasing hormone. 
  • A model system for the biochemical study of luteinizing hormone/chorionic gonadotropin receptor synthesis. 
  • A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. 
  • A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. 
  • A serum-free defined culture system which maintains follicle-stimulating hormone responsiveness and differentiation of porcine granulosa cells. 
  • A study of pituitary function in patients with idiopathic hemochromatosis. 
  • AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level. 
  • Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization. 
  • Amenorrhea: observations based on the analysis of luteinizing hormone-releasing hormone testing. 
  • Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements. 
  • Androgen binding protein as a biochemical marker of formation of the blood-testis barrier. 
  • Androgen control of an inhibitory modulator of phosphodiesterase in rat epididymis and prostate. 
  • Androgens amplify beta-adrenergic and FSH stimulation of granulosa cells. 
  • Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. 
  • Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. 
  • Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. 
  • Are higher pre-diagnosis follicle stimulating hormone levels associated with long-term prostate cancer risk? 
  • Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age 
  • Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. 
  • Basal follicle-stimulating hormone level and age affect the chance for and outcome of pre-embryo cryopreservation. 
  • Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. 
  • Biochemical actions of follice-stimulating hormone in the sertoli cell of the rat testis. 
  • Calcium ions positively modulate follicle-stimulating hormone- and exogenous cyclic 3',5'-adenosine monophosphate-driven transcription of the P450(scc) gene in porcine granulosa cells. 
  • Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1975. 
  • Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. 
  • Changes in (125I) labeled human chorionic gonadotropin (hCG) binding to porcine granulosa cells during follicle development and cell culture. 
  • Characterization and follicle stimulating hormone activation of Sertoli cell cyclic AMP-dependent protein kinases. 
  • Clomiphene citrate in the management of male infertility. 
  • Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. 
  • Concerning the hormonal regulation of androgen binding protein in rat testis. 
  • Concerning the mechanism of FSH action: rapid stimulation of testicular synthesis of nuclear RNA. 
  • Cortisone acetate versus clomiphene citrate in per-germinal idiopathic oligospermia. 
  • Coupled events in the early biochemical actions of FSH on the Sertoli cells of the testis. 
  • Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. 
  • Decreased intracellular potassium levels underlie increased progesterone synthesis during ovarian follicular atresia. 
  • Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study. 
  • Developmental changes in pituitary-gonadal function in free-ranging lions (Panthera leo leo) of the Serengeti Plains and Ngorongoro Crater 
  • Developmental changes in the hormonal regulation of rat testis Sertoli cell adenylyl cyclase. 
  • Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. 
  • Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. 
  • Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. 
  • Early sequence of biochemical events in the action of follicle stimulating hormone on the testis. 
  • Effect of FSH on protein biosynthesis in testes of the immature rat. 
  • Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. 
  • Effect of hysterectomy with ovarian preservation on ovarian function. 
  • Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. 
  • Effects of atrial natriuretic peptide on rat ovarian granulosa cell steroidogenesis in vitro. 
  • Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-alpha knockout mice. 
  • Effects of charcoal-extracted follicular fluid on reproductive function in postpartum cows. 
  • Effects of cytokines on porcine granulosa cell steroidogenesis in vitro. 
  • Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women. 
  • Effects of partially and more highly purified platelet-derived growth factor preparations on luteinizing hormone receptor induction in granulosa cell cultures. 
  • Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. 
  • Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. 
  • Endocrine dysfunction and clomiphene citrate therapy. 
  • Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. 
  • Epidermal growth factor enhances [125I]iodo-follicle-stimulating hormone binding by cultured porcine granulosa cells. 
  • Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression. 
  • Evaluation of danazol as an oral contraceptive. 
  • FSH stimulation of protein kinase inhibitor: regulation of cellular metabolism. 
  • FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist. 
  • FSH-induction of androgen binding protein in testes of Sertoli cell-only rats. 
  • Factors affecting Sertoli cell function in the testis. 
  • Female fertility is reduced in mice lacking Ca2+/calmodulin-dependent protein kinase IV. 
  • Follicle stimulating hormone regulation of protein kinase activity and protein synthesis in testis. 
  • Follicle-stimulating hormone activation of glycogen phosphorylase in the Sertoli cell-enriched rat testis. 
  • Follicle-stimulating hormone concentrations in relation to active and passive smoking. 
  • Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. 
  • Follicle-stimulating hormone, the Sertoli cell, and spermatogenesis. 
  • Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells. 
  • Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. 
  • Gonadotropin regulation of the rat proopiomelanocortin promoter: characterization by transfection of primary ovarian granulosa cells. 
  • Gonadotropin release in patients with androgen insensitivity. Testicular feminization syndrome. 
  • Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment. 
  • Gonadotropin stimulation protocols in the Norfolk IVF program--1988. 
  • Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. 
  • High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. 
  • High doses of gonadotropins have no detrimental effect on in vitro fertilization outcome in normal responders. 
  • High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. 
  • High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. 
  • Hormonal characteristics of free-ranging female lions (Panthera leo) of the Serengeti Plains and Ngorongoro Crater. 
  • Hormonal consequences of "missing the pill". 
  • Hormonal regulation of androgen-binding protein in hypophysectomized rats. 
  • Human chorionic gonadotropin increases the concentration of macrophages in neonatal rat testis. 
  • Human platelet-derived growth factor preparations contain a separate activity which potentiates follicle-stimulating hormone-mediated induction of luteinizing hormone receptor in cultured rat granulosa cells: evidence for transforming growth factor-beta. 
  • Hypofertility and clomiphene citrate therapy. 
  • Hypothalamic and pituitary function in hypogonadotropic hypogonadism. 
  • Impact of a cryopreservation program on the multiple pregnancy rate associated with assisted reproductive technologies. 
  • Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. 
  • In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. 
  • Increased blood pressure in mice lacking cytochrome P450 2J5. 
  • Influence of vitamin A injection before mating on oocyte development, follicular hormones, and ovulation in gilts fed high-energy diets. 
  • Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage. 
  • Interactions between hormones and growth factors in the regulation of granulosa cell differentiation in vitro. 
  • Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. 
  • Interleukin-6: effects on and production by rat granulosa cells in vitro. 
  • Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. 
  • Intracellular mechanisms of gonadotropin-stimulated gene expression in granulosa cells. 
  • Is the timing of implantation affected by zona pellucida micromanipulation? 
  • Isolation and regulation of the protein kinase inhibitor and the calcium-dependent cyclic nucleotide phosphodiesterase regulator in the Sertoli cell-enriched testis. 
  • Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. 
  • Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. 
  • Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. 
  • Luteinizing release hormone tests in impotent diabetic males. 
  • Markers of ovarian reserve as predictors of future fertility. 
  • Mechanisms for the testicular hypertrophy which follows hemicastration. 
  • Modeling endocrine control of the pituitary-ovarian axis: androgenic influence and chaotic dynamics. 
  • Monitoring gonadotropin-stimulated cycles for in vitro fertilization and embryo transfer. 
  • Monolayer growth and differentiated function of porcine and rat granulosa cells following cryopreservation. 
  • New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. 
  • Non-functional ovarian cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization. 
  • Ovarian function following marrow transplantation for aplastic anemia or leukemia. 
  • Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone. 
  • Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients. 
  • Peptide hormone "receptors": specific binding of 3 H-FSH to testis. 
  • Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist. 
  • Physical activity, weight, and waist circumference in midlife women. 
  • Platelet reactivity and thrombogenicity in postmenopausal women. 
  • Platelet-derived growth factor enhances granulosa cell luteinizing hormone receptor induction by follicle-stimulating hormone and serum. 
  • Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. 
  • Protein biosynthesis in the testis. I. Comparison between stimulation by FSH and glucose. 
  • Protein biosynthesis in the testis. V. Concerning the mechanism of stimulation by follicle-stimulating hormone. 
  • Protein kinase inhibitor in sertoli cell-enriched rat testis. Specific regulation by follicle-stimulating hormone. 
  • RELATIONSHIP BETWEEN REPRODUCTIVE AND BONE BIOMARKERS AND OSTEOARTHRITIS IN ZOO ASIAN (ELEPHAS MAXIMUS) AND AFRICAN (LOXODONTA AFRICANA) ELEPHANTS. 
  • Rat granulosa cells express transforming growth factor-beta type 2 messenger ribonucleic acid which is regulatable by follicle-stimulating hormone in vitro. 
  • Regulation of Sertoli cell differentiation by the testicular paracrine factor PModS: analysis of common signal transduction pathways. 
  • Regulation of Sertoli cell differentiation by the testicular paracrine factor PModS: potential role of immediate-early genes. 
  • Regulation of protein kinase inhibitor by follicle-stimulating hormone in Sertoli cells in vitro. 
  • Regulation of the cytoskeleton by Ca2+-calmodulin and cAMP. 
  • Regulation of the macrophage population in postnatal rat testis. 
  • Regulation of the testis sertoli cell by follicle stimulating hormone. 
  • Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. 
  • Results of in vitro fertilization attempts in patients with one or two ovaries. 
  • Role of gonadotropin-releasing hormone pulse frequency in differential regulation of gonadotropins in the gilt. 
  • Sex hormone levels and gonadotrophin release in the polycystic ovary syndrome. 
  • Sex-specific regulation of follicle-stimulating hormone secretion by synaptotagmin 9. 
  • Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. 
  • Sorbitol dehydrogenase of rat testis: changes of activity during development, after hypophysectomy and following gonadotrophic hormone administration. 
  • Specific inhibition of protein kinase A in granulosa cells abolishes gonadotropin regulation of the proopiomelanocortin promoter. 
  • Specific interaction of 3H-FSH with rat testis binding sites. 
  • Staging profile of hypofertile male subjects. 
  • Stimulation protocols for patients with "atypical response". 
  • Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation. 
  • Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. 
  • Synergistic effect of insulin and follicle-stimulating hormone on biochemical and morphological differentiation of porcine granulosa cells in vitro. 
  • Targeted disruption of Mapk14 (p38MAPKalpha) in granulosa cells and cumulus cells causes cell-specific changes in gene expression profiles that rescue COC expansion and maintain fertility. 
  • Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. 
  • Testicular adenosine 3':5'-monophosphate-dependent protein kinase. Regulation by follicle-stimulating hormone. 
  • The bi-modal effects of estradiol on gonadotropin synthesis and secretion in female mice are dependent on estrogen receptor-alpha. 
  • The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. 
  • The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. 
  • The effect of plating density on granulosa cell growth and differentiation in vitro. 
  • The effect of transforming growth factor-beta on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. 
  • The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle. 
  • The influence of follicle-stimulating hormone on testicular phospholipids. 
  • The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. 
  • The physiologic consequences of vas ligation. 
  • The production of androgen binding protein by Sertoli Cells. 
  • The production of transforming growth factor-beta activity by rat granulosa cell cultures. 
  • The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. 
  • The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone. 
  • Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program. 
  • Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. 
  • Transdermal iontophoretic peptide delivery: in vitro and in vivo studies with luteinizing hormone releasing hormone. 
  • Transforming growth factor beta modulates gonadotropin receptor expression in porcine and rat granulosa cells differently. 
  • Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. 
  • Use of hMG and/or FSH for multiple follicle development. 
  • Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. 
  • Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. 
  • [125I]iodo-epidermal growth factor binding and mitotic responsiveness of porcine granulosa cells are modulated by differentiation and follicle-stimulating hormone. 
• 

  Keywords of People

  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute